Ivo Roelants
Director/Board Member at FORMAC Pharmaceuticals NV
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Guy van den Mooter | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | 17 years |
Johan A. Martens | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | 17 years |
Laurent Schueller | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | 14 years |
Chris de Jonghe | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | - |
Brigitte Chanoine | M | 59 |
Université Catholique de Louvain
| - |
Michèle Detaille | F | 67 |
Université Catholique de Louvain
| 19 years |
Pieter Vanthemsche | M | 68 |
Université Catholique de Louvain
| - |
Pierre Scalliet | M | 72 |
Université Catholique de Louvain
| - |
Robert Cobbaut | M | - |
Université Catholique de Louvain
| - |
Michel J. Tilmant | M | 72 |
Université Catholique de Louvain
| - |
Erik Duval | M | - |
Université Catholique de Louvain
| - |
Minne Casteels | M | - |
Université Catholique de Louvain
| - |
Mark Waer | M | - |
Université Catholique de Louvain
| - |
Vic Goedseels | M | 83 |
Université Catholique de Louvain
| 45 years |
Joseph Martin | M | - |
Université Catholique de Louvain
| - |
Alexandra Tolia | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | - |
Michiel van Speybroeck | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | 12 years |
Eric Stroobants | M | 81 |
Université Catholique de Louvain
| - |
Yves-Jacques Schneider | M | - |
Université Catholique de Louvain
| - |
Luc Willame | M | 81 |
Université Catholique de Louvain
| - |
Jean-Pierre Hansen | M | 76 |
Université Catholique de Louvain
| - |
Etienne Marc Sokal | M | - |
Université Catholique de Louvain
| - |
Serge Pampfer | M | - |
Université Catholique de Louvain
| - |
Paul Joseph Rutgeerts | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | 17 years |
Jan Baptist Eduard van Humbeeck | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | 17 years |
François Dupret | M | - |
Université Catholique de Louvain
| - |
Roger Marcel Henri Legras | M | - |
Université Catholique de Louvain
| - |
Jan Delcour | M | - |
Université Catholique de Louvain
| 33 years |
Geert Everaert | M | - |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | - |
Koenraad Debackere | M | 63 |
Université Catholique de Louvain
| 29 years |
Frank P. Luyten | M | 69 |
Université Catholique de Louvain
| - |
Maurice Luc Vandenbroucke | M | 74 |
Université Catholique de Louvain
| - |
Baron Jean Stéphenne | M | 73 |
Université Catholique de Louvain
| - |
Pierre de Muelenaere | M | 65 |
Université Catholique de Louvain
| - |
Françoise de Viron | M | 69 |
Université Catholique de Louvain
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Belgium | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ivo Roelants
- Personal Network